Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
AMB Express|February 1, 2024
Enhancing protein production and growth in chinese hamster ovary cells through miR-107 overexpressionMaryam Jari, Shahriyar Abdoli, Zahra Bazi, et al.
Advanced Pharmaceutical Bulletin|July 29, 2026
Optimizing Expression of a Llama-Based Anti-PSMA Nanobody in Escherichia Coli and Its Application in Immunohistochemistry of Prostate Cancer TissuesSeyedeh Sheila Seyed-Motahari, Shahriyar Abdoli, Mohammad Ali Shokrgozar, et al.
Iranian Biomedical Journal|May 21, 2017
Construction of Various γ34.5 Deleted Fluorescent-Expressing Oncolytic herpes Simplex type 1 (oHSV) for Generation and Isolation of HSV-Based VectorsShahriyar Abdoli, Farzin Roohvand, Ladan Teimoori-Toolabi, et al.
Iranian Biomedical Journal|April 14, 2025
Combination Therapy of Oncolytic Newcastle Virus and Lenalidomide Enhanced Cytotoxicity in Prostate Cancer CellsMahdie Jafari, Shahriyar Abdoli, Majid Asgari, et al.
Cell Journal|October 9, 2024
Development and Characterization of A Novel SpyTagged Modular Nanobody as A Detection Platform for CD22-Positive CellsAmirhosein Maali, Shahriyar Abdoli, Mahdi Habibi-Anbouhi, et al.
Research in Pharmaceutical Sciences|May 21, 2026
PD-1: CD28 chimeric receptors enhance phenotypic and functional features of T cell subsetsSaba Feghhi-Najafabadi, Farhad Riazi-Rad, Mohammad Ali Shokrgozar, et al.
Research in Pharmaceutical Sciences|July 21, 2025
Expression and functional characterization of an anti-CD22 scFv targeting B-cell malignanciesMonireh Gholizadeh, Shahriyar Abdoli, Shafieeh Mansoori, et al.
Frontiers in Immunology|October 31, 2022
Immunovirotherapy: The role of antibody based therapeutics combination with oncolytic virusesMahdie Jafari, Maryam Kadkhodazadeh, Mina Bahrololoumi Shapourabadi, et al.
Reports of Biochemistry & Molecular Biology|August 22, 2020
Expression and Purification of a Bispecific Antibody against CD16 and Hemagglutinin Neuraminidase (HN) in E. Coli for Cancer ImmunotherapyMina Bahrololoumi Shapourabadi, Farzin Roohvand, Arash Arashkia, et al.
Iranian Biomedical Journal|November 4, 2019
Engineered Jurkat Cells for Targeting Prostate-Specific Membrane Antigen on Prostate Cancer Cells by Nanobody-Based Chimeric Antigen ReceptorMahmoud Hassani, Fatemeh Hajari Taheri, Zahra Sharifzadeh, et al.
Pageof 3